ING Group’s Hinge Health HNGE Stock Holding History

ING Group’s Portfolio HNGE Stock Details HNGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7M	Hold	141,000	–	–	0.06%	230
2026 Q1	$5.44M	Hold	141,000	–	–	0.03%	263
2025 Q4	$6.55M	Buy	+141,000	New	+$6.79M	0.04%	245

Other funds holding HNGE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

12CM

11.2 Capital Management Las Vegas, Nevada $205M AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DMC

Deer Management Company Larchmont, New York $812M AUM 2.64% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

ING Group's HNGE Position: Q2 2026 in Review

ING Group held its Hinge Health (HNGE) position steady in Q2 2026 at 141,000 shares worth $11.7M. The position accounts for 0.06% of the portfolio, ranked #230.

ING Group first reported a position in HNGE in Q4 2025 and has held it in 3 quarters since. 277 funds tracked by Wall St. Rank hold HNGE as of Q2 2026.

ING Group held 141,000 shares of Hinge Health worth $11.7M as of Q2 2026.
ING Group left its Hinge Health share count unchanged in Q2 2026.
Hinge Health made up 0.06% of ING Group's portfolio in Q2 2026, its #230 holding.
ING Group first reported a position in Hinge Health in Q4 2025 and has held it in 3 quarters since.
277 funds tracked by Wall St. Rank held Hinge Health as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.